Reconnect Labs
PrivateLast Round
Grant
Aug 20, 2025
Total Funding Raised
$24.64M
Company Overview
Reconnect Labs operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Grant round in August 2025.
Reconnect Labs is a biopharmaceutical company developing precision therapeutics and predictive diagnostics for sleep, anxiety, and substance use disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reconnect Labs Comparables
Compare Reconnect Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reunion Neuroscience Inc. | 81% | |
| Gilgamesh Pharmaceuticals | 79% | |
| GH Research | 79% |
For institutional investors. Book with your work email.
Reconnect Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 20, 2025 | ||||
| Series A | Aug 20, 2025 | ||||
| Seed | May 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reconnect Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lionheart Ventures | Series A, Seed |
| re.Mind Capital | Seed |
| Apeiron Investment Group | Seed |
| Esperante | Series A, Seed |
| Negev Capital | Series A, Seed |
| Noetic Fund | Series A, Seed |
| Innosuisse | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 134% MoM, reaching 2.6K.
- Aug 20, 2025
$11.2M grant received from Innosuisse.
For institutional investors. Book with your work email.
Reconnect Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reconnect Labs's valuation, stock price, and market status.
Is Reconnect Labs a public or private company?
Reconnect Labs is a private company.
What is the current stock price of Reconnect Labs?
Reconnect Labs is a private company, so its shares have no public market price. Caplight tracks Reconnect Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reconnect Labs worth (valuation)?
Valuation information for Reconnect Labs is not publicly available.
Can I buy Reconnect Labs stock?
Reconnect Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reconnect Labs's last funding round?
Reconnect Labs's most recent funding round was Grant on August 20, 2025.
Who are the main investors in Reconnect Labs?
Key investors in Reconnect Labs include Woven Science.
Will Reconnect Labs IPO soon?
No public IPO plans have been announced for Reconnect Labs.
How can I track Reconnect Labs secondary market activity?
Caplight tracks bids, offers, and trades in Reconnect Labs's shares on secondary markets.